137 related articles for article (PubMed ID: 12019897)
21. Chemotoxicity testing of nonionic radiographic contrast media against the blood-brain barrier.
Wilson AJ; Evill CA; Pope LM; Sage MR
Acad Radiol; 1996 Aug; 3 Suppl 2():S331-2. PubMed ID: 8796595
[No Abstract] [Full Text] [Related]
22. Effect of three non-ionic contrast media on rats and rabbits with regard to renal changes. Interspecies comparison.
Bhargava AS; Hofmeister R; Siegmund F; Schöbel C; Günzel P
Arzneimittelforschung; 1990 Jul; 40(7):822-9. PubMed ID: 1977397
[TBL] [Abstract][Full Text] [Related]
23. Response.
McDonald RJ; McDonald JS; Carter RE; Hartman RP; Katzberg RW; Kallmes DF; Williamson EE
Radiology; 2015 Oct; 277(1):306-7. PubMed ID: 26668855
[No Abstract] [Full Text] [Related]
24. Response.
McDonald RJ; McDonald JS; Carter RE; Hartman RP; Katzberg RW; Kallmes DF; Williamson EE
Radiology; 2015 Jun; 275(3):931-2. PubMed ID: 26199958
[No Abstract] [Full Text] [Related]
25. No Association between Intravenous Contrast Material Exposure and Adverse Clinical Outcome: Are Prevention Protocols Effective?
Gramberg MC; Penne EL
Radiology; 2015 Oct; 277(1):306. PubMed ID: 26402500
[No Abstract] [Full Text] [Related]
26. Contrast media-induced nephrotoxicity. Survey and present state.
Golman K; Almén T
Invest Radiol; 1985; 20(1 Suppl):S92-7. PubMed ID: 3972531
[TBL] [Abstract][Full Text] [Related]
27. Comparison between oxygenated iohexol solution enriched with electrolytes and other low-osmotic contrast media. Electrophysiologic and hemodynamic effects during perfusion of the left coronary artery in the pig.
Besjakov J; Chai CM; Bååth L; Almén T
Invest Radiol; 1994 Jun; 29 Suppl 2():S238-41. PubMed ID: 7928244
[No Abstract] [Full Text] [Related]
28. A comparison of the efficacy and safety of iopamidol-370 and iodixanol-320 in patients undergoing multidetector-row computed tomography.
Sahani DV; Soulez G; Chen KM; Lepanto L; Xu JR; Nelson RC; Grazioli L; Vanzulli A; Heiken JP;
Invest Radiol; 2007 Dec; 42(12):856-61. PubMed ID: 18007158
[TBL] [Abstract][Full Text] [Related]
29. Clinical and nephrologic tolerance of iopromide and iotrolan in computed tomography.
Langer M; Langer R; Zwicker C; Speck U; Jänicke UA; Felix R
Invest Radiol; 1991 Nov; 26 Suppl 1():S83-5; discussion S88-91. PubMed ID: 1808156
[No Abstract] [Full Text] [Related]
30. Intravenous contrast material exposure is not an independent risk factor for dialysis or mortality.
McDonald RJ; McDonald JS; Carter RE; Hartman RP; Katzberg RW; Kallmes DF; Williamson EE
Radiology; 2014 Dec; 273(3):714-25. PubMed ID: 25203000
[TBL] [Abstract][Full Text] [Related]
31. The effect of sodium on the fibrillatory propensity of nonionic contrast media.
Piao ZE; Murdock DK; Hwang MH; Raymond RM; Scanlon PJ
Invest Radiol; 1987 Nov; 22(11):895-900. PubMed ID: 3429186
[TBL] [Abstract][Full Text] [Related]
32. Conditioned taste aversion in rats following intrathecal administration of contrast media.
La Noce A; Danieli A; Bertani F; Tirone P; de Haën C
Acta Radiol; 1996 Jan; 37(1):116-20. PubMed ID: 8611314
[TBL] [Abstract][Full Text] [Related]
33. Iopromide. A new non-ionic contrast medium.
Dawson P; Bradshaw A; Hill C
Acta Radiol Diagn (Stockh); 1984; 25(3):253-6. PubMed ID: 6475563
[TBL] [Abstract][Full Text] [Related]
34. Toxicologic profile of iobitridol, a new nonionic low-osmolality contrast medium.
Donandieu AM; Idee JM; Doucet D; Legros A; Penati S; Nain-Dit-Ducret M; Marmion F; Bonnemain B
Acta Radiol Suppl; 1996; 400():17-24. PubMed ID: 8619348
[TBL] [Abstract][Full Text] [Related]
35. Nephrotoxicity of iodixanol versus iopamidol inpatients with chronic kidney disease and diabetes mellitus undergoing coronary angiographic procedures.
Solomon R
Am Heart J; 2010 Feb; 159(2):e7; author reply e9. PubMed ID: 20152210
[No Abstract] [Full Text] [Related]
36. Intravenous contrast material administration at helical 16-detector row CT coronary angiography: effect of iodine concentration on vascular attenuation.
Cademartiri F; Mollet NR; van der Lugt A; McFadden EP; Stijnen T; de Feyter PJ; Krestin GP
Radiology; 2005 Aug; 236(2):661-5. PubMed ID: 16040923
[TBL] [Abstract][Full Text] [Related]
37. Toxicological safety assessment of iomeprol, a new X-ray contrast agent.
Morisetti A; Tirone P; Luzzani F; de Haën C
Eur J Radiol; 1994 May; 18 Suppl 1():S21-31. PubMed ID: 8020516
[TBL] [Abstract][Full Text] [Related]
38. Hemodynamic effects of contrast media during coronary angiography: a comparison of three nonionic agents to Hypaque-76.
Piao ZE; Murdock DK; Hwang MH; Raymond RM; Scanlon PJ
Cathet Cardiovasc Diagn; 1988; 14(1):53-8. PubMed ID: 3349517
[TBL] [Abstract][Full Text] [Related]
39. The effects of the iodinated X-ray contrast media iodixanol, iohexol, iopromide, and ioversol on the rat kidney epithelial cell line NRK 52-E.
Jensen H; Doughty RW; Grant D; Myhre O
Ren Fail; 2011; 33(4):426-33. PubMed ID: 21529272
[TBL] [Abstract][Full Text] [Related]
40. Comparison of the nephrotoxicity between ioversol and iohexol.
Hayami S; Ishigooka M; Suzuki Y; Hashimoto T; Nakada T; Mitobe K
Int Urol Nephrol; 1996; 28(5):615-9. PubMed ID: 9061418
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
